{"slideshow_credits": null, "snippet": "Two drug companies will charge less than $5 a dose to expand protection from the virus known as HPV to millions of girls in the poorest countries.", "abstract": "Merck and GlaxoSmithKline, makers of vaccines against cervical cancer, announce they will cut their prices to world's poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major deadly cancer; disease kills estimated 275,000 women annually in poor countries where Pap tests are impractical and vaccine is far too expensive for average woman to afford.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"lastname": "McNEIL", "qualifier": "Jr", "rank": 1, "firstname": "Donald", "role": "reported", "organization": "", "middlename": "G."}], "original": "By DONALD G. McNEIL Jr", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/05/10/health/prices-cut-for-hpv-cervical-cancer-vaccines-for-neediest.html", "lead_paragraph": "Two drug companies will charge less than $5 a dose to expand protection from the virus known as HPV to millions of girls in the poorest countries.", "headline": {"seo": "Prices Cut for HPV Cervical Cancer Vaccines for Neediest", "main": "Cancer Vaccines Get a Price Cut in Poor Nations", "print_headline": "Cancer Vaccines Get a Price Cut In Poor Nations"}, "_id": "518b8576cf28d05efe001bff", "word_count": "1046", "multimedia": [{"height": 126, "url": "images/2013/05/10/science/jp-vaccine/jp-vaccine-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/05/10/science/jp-vaccine/jp-vaccine-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 693, "url": "images/2013/05/10/science/jp-vaccine/jp-vaccine-articleLarge.jpg", "legacy": {"xlarge": "images/2013/05/10/science/jp-vaccine/jp-vaccine-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "693"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/05/10/science/jp-vaccine/jp-vaccine-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/05/10/science/jp-vaccine/jp-vaccine-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-05-10T00:00:00Z", "source": "The New York Times", "news_desk": "Foreign", "keywords": [{"value": "Vaccination and Immunization", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Cervical Cancer", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Human Papilloma Virus (HPV)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "GAVI Alliance", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "Gardasil (Vaccine)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Cervarix (Vaccine)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Merck & Company Inc", "name": "organizations", "is_major": "Y", "rank": "7"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}